This is a new monthly column that will run down five interesting deals every month that may have flown under the radar.
This month, there were more than 2,000 funding deals given out to VC-backed companies globally, so its easy to miss some that are pretty intriguing.
Every month, well try to run down some that caught our attention here at Crunchbase News. These arent the largest rounds (we already do that) and they may not be from the biggest-named investors (we already do that too). Its just what we found interesting, quirky, notable or maybe a little off-the-wall, which brings us to .
Colossal Biosciences: The Dallas-based company closed a $60 million Series A led by Thomas Tull and At One Ventures. What caught our eye is that this isnt just a normal bioscience firm battling diseaserather its trying to solve de-extinction! Yes, like resurrection biology! (Which Hollywood has shown always turns out poorly, i.e. the whole Jurassic Park franchise).
The companywhich launched five months agois using genome engineering technologies to find a practical working model of de-extinction that will focus on the goal of the restoration and rewilding of functional woolly mammoths to the tundra. Colossal said bringing back mammoths would allow for a better understanding of evolutionary change in other species, and that genetic engineering applications also will help enhance food production and reduce environmental impact.
The other thing that piqued our interest about this were the investors. Thomas Tullof Legendary Entertainment (speaking of movies) and investment firm Tulco famegaming company Animoca Brands, Paris Hilton and several other investors from a variety of areas. A pretty eclectic bunchbut then again, maybe that fits in with the mission.
Grow your revenue with all-in-one prospecting solutions powered by the leader in private-company data.
Beewise: Speaking of saving species, lets talk about the bees. Insight Partners clearly wants to. The huge New York-based private equity/venture firm led an $80 million Series C into Israel-based Beewise, a robotics company that is focused on saving bees from climate change.
The companys proprietary robotic beehivethe Beehomehelps increase pollination capacity and honey production while also helping defend against threats like pesticides and pests. It also is thermally regulated and can even help feed the bees. The company said its tech can help reduce bee mortality by 80 percent, increase yields 50 percent, and eliminate approximately 90 percent of manual labor.
According to the EPA, more than 30 percent of honeybee colonies are disappearing each yeara rate that represents a risk to global food chains. Maybe thats why investors found this deal so sweet and have already poured more than $120 million into Beewise since it was founded in 2018.
Nautilus Labs: The New York-based maritime tech company closed a $34 million Series B this month. The companys tech is pretty cool, as it uses machine-learning to try to help ocean shippers lower emissions and fuel waste while also maximizing commercial returns. In its release on the raise, the company said shipping accounts for 3 percent of anthropogenic greenhouse gas emissionsGHGevery year. While that may not seem like a lot, if the industry does not change, its estimated that number will balloon to 17 percent by 2050.
While the maritime shipping industry and the tech around it is intriguing, the other reason the round made this list is who led the investmentM12 and the Microsoft Climate Innovation Fund. Thats right, Microsofts venture fund and its climate fund both made investmentssimultaneously. Thats the first time that has ever happened. Seems odd, but maybe Microsoft is just really interested in the maritime shipping space.
Pixxel: Yes, everybody seems to be launching satellites nowadays. But Palo Alto, California-based Pixxels earth-imaging tech puts a little different spin on it and is launching the first of its hyperspectral satellites as part of SpaceXs upcoming April Transporter-4 mission.
The company closed a $25 million Series A led by Radical Ventures this month, and will use the cash to advance its earth-imaging microsatellites, which the company says have 50x higher resolution than existing multispectral counterparts. Pixxels hyperspectral imaging allows it to collect data beyond just the visible light spectrum and across about 40x more wavelengths, which could include infrared and ultraviolet frequencies.
The fuller imaging would be able to do more thingsincluding monitor methane emissions or disease outbreaks across agricultural lands. Combining space, moving beyond the visible light spectrum, and helping solve real-world problems can get a company on this list.
Finless Foods: Admittedly, non-sea seafood is not brand new, but it still seemingly gets fewer headlines than faux meat and cheeseand certainly startups that focus strictly on it generally get less attention.
Emeryville, California-based Finless, which creates both cell-cultured and plant-based tuna, closed a $34 million Series B led by Hanwha Solutions this month. Its current focus is the bluefin tuna due to specific pressures on that industry and also its popularity.
Finless is part of the growing number of foodtech companies attracting investor interest as more start to worry about sustainability and food supply. According to Crunchbase numbers, investment into foodtecheverything from fake meat to vertical farmingreached a record $12.8 billion globally in 2021, double the amount of 2020.
Illustration: Dom Guzman
Stay up to date with recent funding rounds, acquisitions, and more with the Crunchbase Daily.
Original post:
5 Interesting Startup Deals You May Have Missed In March: Restoring The Woolly Mammoth, Faux Seafood And Lots Of Bees - Crunchbase News
- genetic engineering summary | Britannica - September 13th, 2024
- The great gene editing debate: can it be safe and ethical? - BBC.com - September 13th, 2024
- Anti-biotechnology campaigners embrace classic crops, are suspicious of hybrid varieties and claim genetic modification violates nature. Heres a... - September 13th, 2024
- Will IL-11 Control Extend Human Life One Day? Early Results are Tantalizing - Securities.io - September 13th, 2024
- Viewpoint: As New Zealand edges toward relaxing its ban on gene edited foods, experts weigh in - Genetic Literacy Project - September 13th, 2024
- Farmers in Brazil and Argentina ramp up growing of genetically-modified drought tolerant wheat that can grow in subtropical regions - Genetic Literacy... - September 13th, 2024
- Scientist explains why we'll never have a real Jurassic Park - and people are crestfallen - indy100 - September 13th, 2024
- Genetic engineering techniques - Wikipedia - January 9th, 2024
- 20.3: Genetic Engineering - Biology LibreTexts - January 9th, 2024
- Genetic engineering - DNA Modification, Cloning, Gene Splicing - December 13th, 2023
- Global Gene Editing Market Poised for Significant Growth, Projected to Reach $14.28 Billion by 2027 - EIN News - December 13th, 2023
- Principles of Genetic Engineering - PMC - National Center for ... - May 17th, 2023
- Quitting: A Life Strategy: The Myth of Perseveranceand How the New Science of Giving Up Can Set You Free - Next Big Idea Club Magazine - May 17th, 2023
- 18 Human Genetic Engineering - Clemson University - March 29th, 2023
- Pros and Cons of Genetic Engineering - Benefits and Risks - March 29th, 2023
- How artificial skin is made and its uses, from treating burns to skin cancer - South China Morning Post - March 29th, 2023
- Genetic Engineering - Meaning, Applications, Advantages and Challenges ... - March 13th, 2023
- Revolutionary Specialty Enzymes Transform Industries, Projected to Reach $2.2 Billion by 2031 - Billion-Dollar - EIN News - March 5th, 2023
- Explained: What is genome editing technology and how is it different from GM technology? - The Indian Express - April 2nd, 2022
- Scribe Therapeutics to Participate in Upcoming Goldman Sachs The New Guard: Privates Leading the Disruption in Healthcare Investor Conference - Yahoo... - April 2nd, 2022
- San Antonio Zoo In Discussions on Woolly Mammoth Project - iHeart - April 2nd, 2022
- Xenotransplantation trials will require adjusting expectations, experts say - STAT - April 2nd, 2022
- Synlogic to Present Data on Phenylketonuria and Homocystinuria Programs at the Society for ... - KULR-TV - April 2nd, 2022
- The Bay Area food tech industry is creating more than vegan burgers. Heres whats next - San Francisco Chronicle - April 2nd, 2022
- Student Startup Teams to Compete For $110000 Cash Prize Pool in U of A's Heartland Challenge - University of Arkansas Newswire - April 2nd, 2022
- Should we test for differences in allergen content between varieties of crops and animal species? - Open Access Government - April 2nd, 2022
- Genetic Engineering - Courses, Subjects, Eligibility ... - December 22nd, 2021
- Scientists Used CRISPR Gene Editing to Choose the Sex of Mouse Pups - Singularity Hub - December 22nd, 2021
- Report calls for broad public deliberation on releasing gene-edited species in the wild - EurekAlert - December 22nd, 2021
- RNA and DNA Extraction Kit Market Study | Know the Post-Pandemic Scenario of the Industry - BioSpace - December 22nd, 2021
- Opinion: Allow Golden Rice to save lives - pnas.org - December 22nd, 2021
- It's time for an alliance of democracies | TheHill - The Hill - December 22nd, 2021
- Aridis Pharmaceuticals Announces a Pan-Coronavirus Monoclonal Antibody Cocktail That Retains Effectiveness Against the Omicron variant, other COVID-19... - December 22nd, 2021
- 2021: when the link between the climate and biodiversity crises became clear - The Guardian - December 22nd, 2021
- Wuhan lab leak now the most likely cause of Covid pandemic and the truth WILL come out, experts tell MPs... - The US Sun - December 22nd, 2021
- Biotech ETFs That Outperformed Last Week - Yahoo Finance - December 22nd, 2021
- Human genetic enhancement - Wikipedia - October 5th, 2021
- Viewpoint: Part 1 Opposition stirred by anti-GMO advocacy group propaganda fading in the developing world, as more countries embrace crop... - October 5th, 2021
- Amyris Partners with Inscripta to Enhance Development of Sustainable Ingredients Using the Onyx Genome Engineering Platform - WWNY - October 5th, 2021
- Kingdom Supercultures raises $25m to expand Non GMO suite of microbes to unlock new flavors, textures, and functionalities in food & beverage -... - October 5th, 2021
- Fact check: Genetically engineering your salad with the COVID-19 vaccines? We're not there yet. - USA TODAY - October 5th, 2021
- Making the Transition from an Academic to a Biobusiness Entrepreneur - Genetic Engineering & Biotechnology News - October 5th, 2021
- Is The New York Times Finally 'Learning To Love GMOS'? - American Council on Science and Health - October 5th, 2021
- Gene editing, joke theft and manifesting - The Week UK - October 5th, 2021
- Opinion: Saving lives through real social justice - Agri-Pulse - October 5th, 2021
- Science, business and the humanities: CP Snow's 'Two Cultures' sixty years on - TheArticle - October 5th, 2021
- Probiotic Yeast Engineered To Produce Beta-Carotene - Technology Networks - April 17th, 2021
- In the US, Imminent Release of Genetically Modified Mosquitoes To Fight Dengue - The Wire Science - April 17th, 2021
- CRISPRoff: A New Addition to the CRISPR Toolbox - Technology Networks - April 17th, 2021
- A Massive New Gene Editing Project Is Out to Crush Alzheimer's - Singularity Hub - April 17th, 2021
- Grammar of the Genome: Reading the Influence of DNA on Disease - Baylor University - April 17th, 2021
- We cannot let China set the standards for 21st century technologies | TheHill - The Hill - April 17th, 2021
- First GMO Mosquitoes to Be Released in the Florida Keys - Singularity Hub - April 17th, 2021
- Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations - BioSpace - April 17th, 2021
- AmunBio and NorthShore University to Advance Cancer Immunotherapy with Engineered Oncolytic Viruses - OncoZine - April 17th, 2021
- StrideBio Announces a Multi-technology License and Master SRA with Duke University to Advance Next-generation Gene Therapies - BioSpace - April 17th, 2021
- ThermoGenesis : The History of Cell and Gene Therapy - marketscreener.com - April 17th, 2021
- EU's refusal to permit GMO crops led to millions of tonnes of additional CO2, scientists reveal - Alliance for Science - Alliance for Science - February 14th, 2021
- New species of fly named after Singanallur Tank - The Hindu - February 14th, 2021
- Son of Monarchs Pays Homage to the Beauty of Migration - Sierra Magazine - February 14th, 2021
- Podcast: TIME's 2020 Kid of the Year, Gitanjali Rao - All Together - Society of Women Engineers - February 14th, 2021
- Geoengineering: What could possibly go wrong? Elizabeth Kolbert's take, in her new book - Bulletin of the Atomic Scientists - February 14th, 2021
- An Introduction to PCR - Technology Networks - February 14th, 2021
- Science Talk - Evolution, cancer and coronavirus how biology's 'Theory of Everything' is key to fighting cancer and global pandemics - The Institute... - February 14th, 2021
- 22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of Hemp/Cannabis Plants with... - February 14th, 2021
- Aleph Farms and The Technion Reveal World's First Cultivated Ribeye Steak - PRNewswire - February 9th, 2021
- Researchers create rice that captures more CO2 with 30 percent more yield - FoodIngredientsFirst - February 9th, 2021
- Interview: Elizabeth Kolbert on why well never stop messing with nature - Grist - February 9th, 2021
- Is Biotechnology the Answer to a More Sustainable Beauty Industry? - Fashionista - February 9th, 2021
- New Jersey arts and entertainment news, features, and event previews. - New Jersey Stage - February 9th, 2021
- CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft... - February 9th, 2021
- Taysha Gene Therapies Announces Collaborations to Advance Next-Generation Mini-Gene Payloads for AAV Gene Therapies for the Treatment of Genetic... - February 9th, 2021
- A new tool to investigate bacteria behind hospital infections - MIT News - February 9th, 2021
- Outlook on the CRISPR Gene Editing Global Market to 2030 - Analysis and Forecasts - GlobeNewswire - February 9th, 2021
- Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization - GlobeNewswire - February 9th, 2021
- Global Lab-On-A-Chip Market Industry Perspective, Comprehensive Analysis, and Forecast 2027||Players-Perkin Elmer Corporation, IDEX, Thermo Fisher... - February 9th, 2021
- Freeline Presents Data on its Gaucher Disease and Fabry Disease AAV-Based Gene Therapies at the 17th Annual WORLDSymposium - PharmiWeb.com - February 9th, 2021
- Global Bacterial and Plasmid Vectors Market Report 2020: Market is Expected to Recover and Reach $0520 Million in 2023 at a CAGR of 15.48% - Forecast... - January 12th, 2021
- mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry - TIME - January 12th, 2021
- Moss-based expression firm receives 60m in funding - BioProcess Insider - BioProcess Insider - January 12th, 2021